Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,000 shares at $270.63 ($277K) on 2020-03-03, disclosed to the SEC on 2020-03-04.
Scheduled sale ($277k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $270.63 | 107 | $29K | 10.5% |
| 2 | $271.54 | 152 | $41K | 14.9% |
| 3 | $272.82 | 81 | $22K | 8.0% |
| 4 | $274.88 | 155 | $43K | 15.4% |
| 5 | $275.56 | 114 | $31K | 11.3% |
| 6 | $277.48 | 64 |
| $18K |
| 6.4% |
| 7 | $279.60 | 31 | $9K | 3.1% |
| 8 | $281.61 | 53 | $15K | 5.4% |
| 9 | $282.77 | 84 | $24K | 8.6% |
| 10 | $285.48 | 75 | $21K | 7.7% |
| 11 | $288.26 | 84 | $24K | 8.7% |
| Total | $277.08 avg | 1,000 | $277K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |